SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017583
Filing Date
2022-11-14
Accepted
2022-11-14 07:47:13
Documents
59
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20220930x10q.htm   iXBRL 10-Q 1138371
2 EX-31.1 zyne-20220930xex31d1.htm EX-31.1 11482
3 EX-31.2 zyne-20220930xex31d2.htm EX-31.2 11219
4 EX-32.1 zyne-20220930xex32d1.htm EX-32.1 6128
5 EX-32.2 zyne-20220930xex32d2.htm EX-32.2 6149
6 GRAPHIC zyne-20220930x10q001.jpg GRAPHIC 65112
  Complete submission text file 0001558370-22-017583.txt   5282940

Data Files

Seq Description Document Type Size
7 EX-101.SCH zyne-20220930.xsd EX-101.SCH 38953
8 EX-101.CAL zyne-20220930_cal.xml EX-101.CAL 42206
9 EX-101.DEF zyne-20220930_def.xml EX-101.DEF 146454
10 EX-101.LAB zyne-20220930_lab.xml EX-101.LAB 308574
11 EX-101.PRE zyne-20220930_pre.xml EX-101.PRE 250099
53 EXTRACTED XBRL INSTANCE DOCUMENT zyne-20220930x10q_htm.xml XML 960976
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 221380342
SIC: 2834 Pharmaceutical Preparations